ArticleDysphagia2026
Impacts of a Group-Based Intervention To Mitigate Concurrent Chemotherapy and Radiotherapy-Induced Dysphagia: A Retrospective Cohort Study.
Article in Dysphagia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Oropharyngeal dysphagia is a prevalent and clinically significant toxicity in patients with head and neck cancer undergoing concurrent chemotherapy and radiotherapy (CCRT). Preventive swallowing interventions, including exercise-based programs initiated during CCRT, are increasingly adopted in clinical practice to minimize CCRT-induced dysphagia. However, maintaining consistent therapeutic adherence remains a major clinical challenge, potentially limiting the effectiveness of these interventions. This study aimed to examine the impacts of a group-based prophylactic swallowing intervention in patients with head and neck cancer (HNC) treated with concurrent chemotherapy and radiotherapy (CCRT). We conducted a retrospective cohort study examining (a) swallowing-related outcomes, (b) therapy attendance and (c) health-related quality of life (HRQOL) outcomes in patients who participated in either (1) an individual prophylactic swallowing intervention (I-PSI), or (2) a group-based prophylactic swallowing intervention (GB-PSI) using Bayesian regression models. Data from 188 medical charts (I-PSI: n = 101; GB-PSI = 87) were included for analysis. Patients in the GB-PSI cohort had a significantly lower probability of reactive nasogastric tube placement compared to the I-PSI cohort (-0.14 [-0.27, -0.06]). They presented with significantly lower dysphagia toxicity grades during CCRT (-0.48 [-0.32, -0.71]) and at treatment completion (-0.44 [-0.27, -0.63]), along with a lower probability of experiencing grade dysphagia at the end of CCRT (-0.2 [-0.07, -0.32]). The GB-PSI cohort attended more therapy sessions during CCRT (1.76 [1.18, 2.1]) but needed fewer swallowing therapy sessions following treatment completion (-0.52 [-0.92, -0.09]). The small sample size for HRQOL did not allow for statistical analysis. Results suggest that a group-based prophylactic swallowing intervention may be a valuable option for patients undergoing CCRT for HNC. Prospective studies are needed to further explore its impact on therapeutic adherence and a broader range of swallowing-related outcomes.
Indexed as
Identifiers
41627396What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.